Pulmonary delivery of Nanocomposite Microparticles (NCMPs) incorporating miR-146a for treatment of COPD-Reference-Cited by-同舟云学术

Pulmonary delivery of Nanocomposite Microparticles (NCMPs) incorporating miR-146a for treatment of COPD

Published:2019-10 Issue: Volume:569 Page:118524
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Mohamed Adel,Pekoz Ayca Y.,Ross Kehinde,Hutcheon Gillian A.,Saleem Imran Y.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference68 articles.

1. Pulmonary delivery of proteins using nanocomposite microcarriers;Alfagih;J. Pharm. Sci.,2015

2. Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery;Beck-Broichsitter;J. Control. Release,2012

3. Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors;Beg;Invest. New Drugs,2017

4. Interactions and incompatibilities of pharmaceutical excipients with active pharmaceutical ingredients: a comprehensive review;Bharate;J. Excipients Food Chem.,2016

5. PLGA nanoparticles stabilized with cationic surfactant: safety studies and application in oral delivery of paclitaxel to treat chemical-induced breast cancer in rat;Bhardwaj;Pharm. Res.,2009

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNAs as promising drug delivery target to ameliorate chronic obstructive pulmonary disease using nano-carriers: a comprehensive review;Molecular and Cellular Biochemistry;2024-09-10

2. Nanomaterials-assisted gene editing and synthetic biology for optimizing the treatment of pulmonary diseases;Journal of Nanobiotechnology;2024-06-18

3. Spray-drying of PEI-/PPI-based nanoparticles for DNA or siRNA delivery;European Journal of Pharmaceutics and Biopharmaceutics;2024-06

4. A new frontier in precision medicine: Exploring the role of extracellular vesicles in chronic obstructive pulmonary disease;Biomedicine & Pharmacotherapy;2024-05

5. Current advances in the therapeutic potential of nanomedicines for pulmonary disorders;Emergent Materials;2024-04-24